1. Berson A, Descatoire V, Sutton A, Fau D, Maulny B, Vadrot N, Feldmann G, Berthon B, Tordjmann T, Pessayre D (2001) Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes: role of mitochondrial permeability transition and metabolic activation. J Pharmacol Exp Ther 299:793–800
2. Fagius J, Osterman PO, Sidén A, Wiholm BE (1985) Guillain-Barré syndrome following zimeldine treatment. J Neurol Neurosurg Psychiatry 48:65–69
3. Glassman AH (2005) Schizophrenia, antipsychotic drugs, and cardiovascular disease. J Clin Psychiatry 66(Suppl 6):5–10
4. Harmark L, van Groothest AC (2008) Pharmacovigilance: methods recent developments and future perspectives. Eur J Pharmacol 64:743–752
5. Lazaros GA, Stavrinos C, Papatheodoridis GV, Delladetsima JK, Toliopoulos A, Tassopoulos NC (1996) Amineptine induced liver injury. Report of two cases and brief review of the literature. Hepatogastroenterology 43:1015–1019